Rockwell heralds PhIII success for iron-delivery drug; Combined drugs could help treat HIV;

> Rockwell Medical ($RMTI) welcomed positive results in a Phase III study for its iron-delivery drug, showing the treatment increased hemoglobin in patients receiving hemodialysis. More

> Researchers at the University of Minnesota have developed a delivery system that combines two FDA-approved drugs that, together, could be an effective treatment for HIV. Story

> MusclePharm Corporation invested $2 million in BioZone, which has a drug delivery platform, QuSome, that enhances the absorption of topical and other drugs. Release